Abstract
Design, screening and development of drugs to combat CoVid-19 is important during the viral outbreak. Therefore, it is of interest to document the molecular docking analysis data of ACE-2 and SARS-CoV-2 spike (S) glycoprotein with known phytocompounds from Mammea suriga in comparision with standard drug and tinosporin an antiviral phytocompound. We report the optimal binding features of, β-Sitosterol acetate, 1-acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydroquinoline, D-Homo-24-nor-17-oxachola-20,22-diene-3,16-dione,1,2:14,15:21,23-triepoxy-7-hydroxy, Taraxeron and Tinosporin with ACE-2 and SARS-CoV-2 spike (S) glycoprotein for further consideration. Funding: The authors are thankful to DBT, New Delhi, India, for providing financial support through the DBT-BUILDER program (Order No. BT/PR9128/INF/22/190/2013, Dated: 30/06/2015). Declaration of Interest: Authors state that there is no conflict of interest
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
